Skip to main content
Welcome to "The Poster!" To become a subscriber and start getting updates on new content, subscribe now!

In the News

Scientific Library | More than 3,200 Books and DVDs Donated to Annual Book Swap

The Scientific Library’s 14th Annual Book and Media Swap, held on April 16 in the lobby of Building 549, proved to be a popular event. When the swap was rescheduled from fall 2013 to spring 2014, the library staff was uncertain if the response would be equal to previous years, said Sue Wilson, principal manager of the Scientific Library. NCI at Frederick employees rose to the challenge, however, with 87 people donating more than 3,200 books and DVDs, according to Pam Noble, serials technician and book swap team leader.

Health & Safety | Weather Advisory: Tornados

Summer months carry the threat of severe storms and tornados in our area. Take a few moments to consider how well you are prepared in the event of a tornado warning. The time to prepare for a tornado is before it happens. The Federal Emergency Management Agency (FEMA) provides information on how to prepare and what to do in the event of a tornado.

Science & Technology | New Animal Model Could Boost Research on AIDS Drugs and Vaccines

In a research milestone reported in the June 20 issue of the journal Science, scientists have developed a minimally modified version of HIV-1, the virus that causes AIDS in infected humans, that is capable of causing progressive infection and AIDS in monkeys. The advance should help create more authentic animal models of the disease and provide a potentially invaluable approach for faster and better preclinical evaluation of new drugs and vaccines.

Community | New Hires at the National Cancer Institute at Frederick

Fifty-six people joined the facility in January, February, and March 2014.

Science & Technology | NCI Researchers Discover Exceptionally Potent Antibodies with Potential for Prophylaxis and Therapy of MERS-Coronavirus Infections

In a recent article published in the Journal of Virology, Tianlei Ying, Ph.D., Dimiter Dimitrov, Ph.D., and their colleagues in the Laboratory of Experimental Immunology, Cancer and Inflammation Program, NCI Center for Cancer Research, reported the identification of three human monoclonal antibodies (m336, m337, and m338) that target the part of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) that is responsible for binding to its receptor.